© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Gilead Sciences, Inc. (GILD) shows an Average True Range (ATR) of 3.01 and an Enterprise Value of 102.55B. Its average trading volume over the past 3 months is 7.36M, indicating liquidity. These fundamental metrics provide insight into GILD's underlying financial health and market activity.
Gilead Sciences, Inc. (GILD) technical indicators as of December 23, 2025: the SMA 20 is 1.02%, SMA 50 at 1.53%, and SMA 200 at 9.51%. The RSI 14 value is 54.78, suggesting its current momentum. These technical analysis signals help assess GILD's price trends and potential future movements.
Gilead Sciences, Inc. (GILD) stock performance overview as of December 23, 2025: The 52-week high is $128.7 (currently -3.53% below), and the 52-week low is $88.57 (currently 40.18% above). Over the past year, GILD's performance is 34.88%, compared to the S&P 500's 12.87% change.
According to market data, Gilead Sciences, Inc. (GILD) stock's recent performance metrics show that over the last month, GILD is -3.05%, with a Year-to-Date (YTD) performance of 34.42%. Over the past year, the stock has seen a 34.88% change. These figures summarize GILD's price movements across various periods, reflecting its historical returns.
According to current financial data, GILD stock's P/E (TTM) ratio is 19.00, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for GILD, including P/S (5.29), P/B (7.18), and P/FCF (16.15), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.